Search Login Register

Infectious Mononucleosis (Glandular Fever) Summary

Description: A common, acute infection usually caused by the Epstein-Barr virus (HERPESVIRUS 4, HUMAN). There is an increase in mononuclear white blood cells and other atypical lymphocytes, generalized lymphadenopathy, splenomegaly, and occasionally hepatomegaly with hepatitis.

Also Known As: Glandular Fever; Mononucleosis, Infectious; Fever, Glandular

Networked: 1305 relevant articles (23 outcomes, 90 trials/studies) for this Disease

Key Drugs and Agents for Infectious Mononucleosis

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Immunoglobulin M (IgM) : 2 outcomes 9 studies in 119 results : IBA
  2. Membrane Proteins (Integral Membrane Proteins) : 2 outcomes 2 studies in 14 results : IBA
  3. 10-carboxymethyl-9-acridanone : 2 outcomes in 3 results : IBA
  4. Tinidazole : 2 outcomes in 2 results : FDA 3
  5. Antigens : 1 outcome 14 studies in 166 results : IBA
  6. Immunoglobulin G (IgG) : 1 outcome 7 studies in 82 results : IBA
  7. Immunoglobulins (Immunoglobulin) : 1 outcome 2 studies in 36 results : IBA
  8. Biological Markers (Surrogate Marker) : 1 outcome 2 studies in 3 results : IBA
  9. Steroids : 1 outcome 1 study in 9 results : IBA
  10. Metronidazole (Metric) : 1 outcome 1 study in 7 results : FDA 70 Generic
Show All >>

Diseases Related to Infectious Mononucleosis

  1. Epstein-Barr Virus Infections
  2. Neoplasms (Cancer)
  3. Thrombocytopenia (Thrombopenia)
  4. Pharyngitis (Sore Throat)
  5. Non-Hodgkin Lymphoma (Lymphosarcoma)
Show All >>

Key Therapies for Infectious Mononucleosis

Efficacy Chart >>
  1. Transplants (Transplant) : 3 studies in 33 results
  2. Tonsillectomy : 2 studies in 18 results
  3. Transplantation (Transplant Recipients) : 2 studies in 17 results
  4. Splenectomy : 17 results
  5. Homologous Transplantation (Allograft) : 6 results
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.